{
    "Trade/Device Name(s)": [
        "Total Immunoglobulin E (IgE)"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K220178",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061970"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DGC"
    ],
    "Summary Letter Date": "March 23, 2022",
    "Summary Letter Received Date": "January 21, 2022",
    "Submission Date": "January 20, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, And E Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "allergy"
    ],
    "Analyte(s)": [
        "Total Immunoglobulin E (IgE)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU/DxC AU clinical chemistry analyzers",
        "DxC 700 AU Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Total Immunoglobulin E (IgE) turbidimetric immunoassay for quantitative measurement of IgE using AU/DxC AU clinical chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of Total Immunoglobulin E (IgE) concentration in human serum and plasma on Beckman Coulter AU/DxC AU clinical chemistry analyzers; aids diagnosis of IgE-mediated allergic disorders in conjunction with other clinical findings",
    "fda_folder": "Immunology"
}